HealthCare Market Analysis

The global  medical image analysis software market  size is expected to reach USD 4.51 billion by 2024, according to a new report by Grand View Research, Inc., registering an 8.1% CAGR during the forecast period. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs demand for medical image analysis software. High growth of the industry is majorly attributed to increase in usage and uptake of image analysis solutions for diagnosis. In addition, shifting focus to provide enhanced care has led to incorporation of various computer aided diagnosis systems, which is further contributing toward growth. Introduction of technologically advanced products such as 3D/4D platforms and multimodality imaging platforms is also presumed to augment growth over the coming years. Various benefits such as flexibility and high-resolution images, along with convenient use of multi-modal integrated workflows, are expected to bolst...

The global  cancer biomarkers market  is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers. In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research. U.S. cancer biomarkers mar...

The  U.S. surgical microscopes market  size is expected to reach USD 385.2 million by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.7% during the forecast period. Increasing prevalence of chronic disorders such as cancer and cardiovascular diseases, which require surgical intervention, is anticipated to bolster the growth of the operating microscopes market over the forecast period. According to the Center for Disease Control and Prevention (CDC) in 2014, the cancer prevalence rate in the U.S. was in the range of 380.4-510.7 incidents per 100,000 people. States with the highest cancer incidence rates were Kentucky, Delaware, Pennsylvania, Maine, New Hampshire, Louisiana, Connecticut, New York, Iowa, and Michigan. These states are estimated to have greater demand for the product due to the requirement of more frequent surgical interventions. Awareness regarding advantages of minimally invasive surgeries is also expect...